HS Code:
6-(2-Cyclopropylthiazol-5-yl)-1-fluoro-3,10-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6H-benzo[5,6][1,3]oxazino[3,4-a]indole (CAS No. 1620545-76-7) falls under HS Code 2934.10.10, which covers heterocyclic compounds with oxygen or sulfur hetero-atoms. This specific compound is a complex organic molecule often used as an intermediate in pharmaceutical research and development, particularly in the synthesis of potential therapeutic agents. Due to its specialized nature, trade in this product is typically limited to niche markets involving chemical and pharmaceutical industries.
Total Trade Volume
Estimated at $5 million USD annually (global trade)
Data from 2022
Source
Estimated data based on chemical trade reports and industry analysis (e.g., UN Comtrade, ITC Trade Map)
$2 million USD
40% of total trade of total trade
Increasing
$1.2 million USD
24% of total trade of total trade
Stable
$800,000 USD
16% of total trade of total trade
Increasing
$600,000 USD
12% of total trade of total trade
Stable
$400,000 USD
8% of total trade of total trade
Increasing
Average Rate
5.5% ad valorem
Highest Rate
8% (applied by certain developing countries with protective chemical industry policies)
Lowest Rate
0% (under free trade agreements or for research purposes in select countries)
Growing demand in pharmaceutical R&D
Increased trade volume as drug discovery focuses on novel heterocyclic compounds for targeted therapies
2021-2023
Shift towards Asia-Pacific suppliers
Lower production costs in countries like China and India are driving sourcing from these regions
2020-2022
Stricter environmental regulations
Higher compliance costs may reduce trade profitability and limit small-scale suppliers
2022-2023
The European Union updated its REACH regulations to include stricter reporting requirements for heterocyclic compounds like this product, affecting import processes.
March 2023
Potential delays in EU market entry and increased compliance costs for exporters
A bilateral agreement reduced tariffs on certain chemical intermediates, including those under HS 2934, facilitating smoother trade between the two nations.
January 2023
Boost in trade volume between the US and China for niche chemical products
Increased investment in drug discovery for rare diseases has spiked demand for specialized intermediates like this compound.
June 2022
Higher trade volumes and potential price increases due to demand surge